Thomas Massie vs the Israel Lobby: $20 Million, Epstein Files and the Fight Over Who Owns Congress
Rep. Thomas Massie has turned his primary into a referendum on foreign influence, AIPAC-style spending and Epstein transparency. But the claims need precision: influence is real, proof still matters.
Thomas Massie has never looked like a normal Washington Republican. Now his race has become something bigger than a Kentucky primary: a fight over Israel, campaign money, the Epstein files and whether American foreign policy is being bought in plain sight.
The viral version says Israel is preparing to spend nearly $20 million to destroy Massie after he exposed the Epstein files. The careful version is more complicated. Haaretz reported that Massie introduced legislation aimed at AIPAC-style influence shortly before a hugely expensive primary fight. The Washington Post and other outlets have documented Massie’s conflict with Trump and his push for Epstein transparency. Axios has reported unrelated personal and political allegations surfacing ahead of the election. In short, Massie is under pressure from multiple directions.
The core issue, however, is real: outside money has become a major force in U.S. politics, and pro-Israel advocacy groups are among the most organized and effective players.
Massie’s argument is simple. Foreign-aligned interests, even when operating through American donors and legal political committees, can distort democratic accountability. If a member of Congress fears a multimillion-dollar campaign for questioning aid to Israel, then the debate is not fully free.
Supporters of AIPAC and similar groups reject that framing. They argue they represent American citizens who believe the U.S.-Israel alliance is strategically and morally important. In their view, campaign spending is democratic participation, not foreign control. They also argue that critics often single out pro-Israel spending while ignoring other powerful lobbies: defense contractors, pharmaceuticals, energy, tech, unions, trial lawyers and ideological billionaires.
Both sides have a point.
It is true that pro-Israel political networks are not the only influence machine in Washington. It is also true that their power is unusually sensitive because it touches war, aid, intelligence, Middle East policy and free speech. When the United States is spending tens of billions in a regional war involving Iran and Israel, the question of who shapes congressional incentives becomes urgent.
Massie has sharpened that question by tying it to the Epstein files. He has repeatedly demanded transparency around documents related to Jeffrey Epstein, and he has suggested that powerful interests want the issue buried. That claim resonates because Epstein’s network included wealthy, politically connected people across multiple countries. But resonance is not proof. A responsible article cannot claim that Israel as a state is attacking Massie because of Epstein unless documents establish that link.
What can be said is this: Massie has positioned himself as one of the loudest Republican critics of unconditional support for Israel, and he is now facing a costly, high-stakes political fight. That alone is worth scrutiny.
The larger question is whether Americans are comfortable with foreign-policy red lines being enforced through domestic campaign spending. If a politician can support endless aid and face no consequences, but question that aid and immediately face millions in attack ads, then voters should at least know who is paying.
Transparency is the minimum standard. Every dollar should be traceable. Every donor network should be visible. Every group lobbying on behalf of a foreign ally should be scrutinized under the same rules, whether the ally is Israel, Saudi Arabia, Ukraine, Qatar, Turkey, China or anyone else.
Massie’s critics say he is exploiting anti-Israel sentiment for political gain. His supporters say he is one of the few politicians willing to say what others whisper privately: that Congress is too easily pushed into wars and aid packages that voters never truly debated.
The truth may not fit either slogan. Massie may be politically opportunistic and still raise a real issue. AIPAC may represent genuine American opinion and still exercise disproportionate power. Israel may be a U.S. ally and still deserve normal scrutiny.
That is the debate Washington avoids because the accusation is so dangerous. Say too little, and money keeps shaping policy in the dark. Say too much, and legitimate criticism gets dragged into conspiracy.
Massie’s race is therefore not just about one congressman. It is about whether American democracy can discuss foreign influence without censorship, hysteria or ethnic blame.
The question is not whether Israel has supporters in Congress. Of course it does. The question is whether American voters are still the final authority — or whether billion-dollar narratives and million-dollar primaries now decide what can be said.